Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych: cancer drug

Sortuj według:

Ogranicz wyniki do:

Advances with phospholipid signalling as a target for anticancer drug development

100%

Powis G., Berggren M., Gallegos A., Frew T., Hill S., Kozikowski A., Bonjouklian R., Zalkow L., Abraham R., Ashendel C., Schultz R., Merriman R.

Acta Biochimica Polonica

1995

tom 42

nr 4

The phosphatidylinositol-3-kinases (PtdIns-3-kinase) are a family of enzymes involved in the control of cell replication. One member of the family, the mammalian pll0/p85 PtdIns-3-kinase, is a potential target for anticancer drug development because of its role as a component of growth factor and oncogene activated signalling pathways. There are a number of inhibitors of this PtdIns-3-kinase, the most potent being wortmannin (IC50 4 nM). Wortmannin inhibits cancer cell growth and has shown activity against mouse and human tumor xenografts in mice. Other inhibitors of the PtdIns-3-kinase are halogenated quinones which also inhibit cancer cell growth and have some in vivo antitumor activity. Some D-3-deoxy-3-substituted mt/o-inositol analogues and their corresponding Ptdlns analogues have been synthesized. They may act as mi/o-inositol antimetabolites in the PtdIns-3-kinase pathway and they can inhibit cancer cell growth.

Ograniczanie wyników

1 Acta Biochimica Polonica

1 Abraham R.

1 Ashendel C.

1 Berggren M.

1 Bonjouklian R.

1 Frew T.

1 Gallegos A.

1 Hill S.

1 Kozikowski A.

1 Merriman R.

1 Powis G.

1 Schultz R.

1 Zalkow L.

1 1995

Wyniki wyszukiwania

Advances with phospholipid signalling as a target for anticancer drug development